ARKG vs SPXU

ARK Genomic Revolution ETF vs ProShares UltraPro Short S&P500

Quick take
  • ARKG has the lower expense ratio at 0.75% vs 0.90% for SPXU.
  • SPXU pays a higher dividend yield (6.87%).

Side-by-side metrics

MetricARKGSPXU
Expense ratio
Annual fee. Lower is better.
0.75%0.90%
Dividend yield
Trailing 12-month yield.
0.00%6.87%
AUM
Assets under management — bigger funds are typically more liquid.
$1.24B$562M
YTD return
7.21%-19.75%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.35-2.75
P/E ratio
Last price
$30.38$39.97
Inception
Issuer
ARKProShares

ARKG top holdings

Top holdings · ARKG
TEMTempus AI Inc Class A common stock9.45%
TWSTTwist Bioscience Corp9.02%
CRSPCRISPR Therapeutics AG8.94%
TXG10x Genomics Inc Ordinary Shares - Class A5.78%
BEAMBeam Therapeutics Inc5.44%
ABSIAbsci Corp4.79%
NTRANatera Inc4.08%
ILMNIllumina Inc4.04%
NTLAIntellia Therapeutics Inc3.83%
PSNLPersonalis Inc3.59%
Sector breakdown · ARKG
Healthcare100.0%

SPXU top holdings

Top holdings · SPXU
IQMMProShares GENIUS Money Market ETF68.61%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About SPXU

SPXU (ProShares UltraPro Short S&P500) is 3x inverse daily performance of the S&P 500. Managed by ProShares, the fund carries $562M in assets under management, an expense ratio of 0.90%, a dividend yield of 6.87%. Its largest holding is ProShares GENIUS Money Market ETF (IQMM), which represents 68.6% of the portfolio.